HDAC9 and prostate carcinoma: In human prostate cancer PC-3 cells, apigenin (20–40 μM) acts as a potent HDAC inhibitor, which induces noticeable suppression of the HDAC protein activity (41% and 62%), especially HDAC1 and HDAC3 [192].